Distinct EMT programs control normal mammary stem cells and tumour-initiating cells

Nature

Volumn 525, Issue 7568, 2015, Pages 256-260

  Ye, Xin ^a   Tam, Wai Leong ^a,b,c   Shibue, Tsukasa ^a   Kaygusuz, Yasemin ^a   Reinhardt, Ferenc ^a   Ng Eaton, Elinor ^a   Weinberg, Robert A ^a,d  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b GENOME INSTITUTE OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; PROTEIN P53; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SOX9; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR ZEB1; UVOMORULIN; SNAIL FAMILY TRANSCRIPTION FACTORS; SOX9 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

CANCER; CELLS AND CELL COMPONENTS; GENE EXPRESSION; GENETIC ENGINEERING; PHYSIOLOGICAL RESPONSE; PROTEIN; RODENT; SNAIL; TUMOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASEMENT MEMBRANE; BREAST CANCER CELL LINE; BREAST CARCINOGENESIS; BREAST EPITHELIUM; BREAST EPITHELIUM CELL; CELL CULTURE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; TUMOR CELL; TUMOR INITIATING CELL; TUMOR XENOGRAFT; ANIMAL; CANCER STEM CELL; COMPARATIVE STUDY; CYTOLOGY; DEFICIENCY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; UDDER;

GASTROPODA;

ANIMALS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; MAMMARY GLANDS, ANIMAL; MICE; NEOPLASTIC STEM CELLS; SOX9 TRANSCRIPTION FACTOR; STEM CELLS; TRANSCRIPTION FACTORS;

EID: 84941243013     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature14897     Document Type: Article

References (35)

1. Al-Hajj, M., Clarke, M. F. Self-renewal and solid tumor stem cells. Oncogene 23, 7274-7282 (2004).
2. O'Brien, C. A., Kreso, A., Dick, J. E. Cancer stem cells in solid tumors: an overview. Semin. Radiat. Oncol. 19, 71-77 (2009).
3. Visvader, J. E., Lindeman, G. J. Cancer stem cells: current status and evolving complexities. Cell Stem Cell 10, 717-728 (2012).
4. Chaffer, C. L. et al. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc. Natl Acad. Sci. USA 108, 7950-7955 (2011).
5. Gupta, P. B. et al. Stochastic state transitions give rise to phenotypic equilibriumin populations of cancer cells. Cell 146, 633-644 (2011).
6. Beck, B., Blanpain, C. Unravelling cancer stem cell potential. Nature Rev. Cancer 13, 727-738 (2013).
7. Kreso, A., Dick, J. E. Evolution of the cancer stem cell model. Cell Stem Cell 14, 275-291 (2014).
8. Guo, W. et al. SlugandSox9 cooperatively determine themammary stemcell state. Cell 148, 1015-1028 (2012).
9. Shackleton,M. et al.Generation of a functionalmammary gland froma single stem cell. Nature 439, 84-88 (2006).
10. Stingl, J. et al. Purification andunique properties ofmammary epithelial stemcells. Nature 439, 993-997 (2006).
11. Prater, M. D. et al. Mammary stem cells havemyoepithelial cell properties. Nature Cell Biol. 16, 942-950 (2014).
12. Lin, E. Y. et al. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am. J. Pathol. 163, 2113-2126 (2003).
13. Cheung, K. J., Gabrielson, E., Werb, Z., Ewald, A. J. Collective invasion in breast cancer requires a conserved basal epithelial program. Cell 155, 1639-1651 (2013).
14. Lim, E. et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nature Med. 15, 907-913 (2009).
15. Molyneux, G. et al. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 7, 403-417 (2010).
16. Visvader, J. E. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev. 23, 2563-2577 (2009).
17. Visvader, J. E. Cells of origin in cancer. Nature 469, 314-322 (2011).
18. Muller, W. J., Sinn, E., Pattengale, P. K., Wallace, R.& Leder, P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54, 105-115 (1988).
19. Xu, X. et al. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nature Genet. 22, 37-43 (1999).
20. Moody, S. E. et al. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 8, 197-209 (2005).
21. Tran, H. D. et al. Transient SNAIL1 expression is necessary for metastatic competence in breast cancer. Cancer Res. 74, 6330-6340 (2014).
22. Papageorgis, P. et al. Smad signaling is required to maintain epigenetic silencing during breast cancer progression. Cancer Res. 70, 968-978 (2010).
23. Natrajan, R. et al. An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers. Breast Cancer Res. Treat. 121, 575-589 (2010).
24. Gyorffy, B. et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis usingmicroarray data of1,809 patients. Breast Cancer Res. Treat. 123, 725-731 (2010).
25. Nieto, M. A. The snail superfamily of zinc-finger transcription factors. Nature Rev. Mol. Cell Biol. 3, 155-166 (2002).
26. Chaffer, C. L. et al. Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 154, 61-74 (2013).
27. Siebzehnrubl, F. A. et al. The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance. EMBO Mol. Med. 5, 1196-1212 (2013).
28. Wellner, U. et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nature Cell Biol. 11, 1487-1495 (2009).
29. Thiery, J. P., Acloque, H., Huang, R. Y., Nieto, M. A. Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890 (2009).
30. Guaita, S. et al. Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J. Biol. Chem. 277, 39209-39216 (2002)
31. Tam,W. L. et al. Protein kinaseCa is a central signaling node and therapeutic target for breast cancer stem cells. Cancer Cell 24, 347-364 (2013).
32. Hu, Y., Smyth, G. K. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J. Immunol. Methods 347, 70-78 (2009).
33. Shibue, T., Brooks, M. W., Weinberg, R. A. An integrin-linked machinery of cytoskeletal regulation that enables experimental tumor initiation and metastatic colonization. Cancer Cell 24, 481-498 (2013).
34. Gupta, P. B. et al. The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nature Genet. 37, 1047-1054 (2005).
35. Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).